Immunohistochemical analysis on glioblastoma TMA cores showed variable cytoplasmic expression of IDO1, IDO2, and TDO2, while AhR showed variable nuclear expression in tumour cells across GBM patients. The gene discussed is IDO2; the disease is neoplasm.